New autoantigens in rheumatoid arthritis (RA): screening 8268 protein arrays with sera from patients with RA

Isabelle Auger (1, 2) , N Balandraud (1, 2) , J Rak (1, 2) , N. Lambert (3, 1, 2) , M. Martin (1, 2) , J Roudier (1, 2)

1 Immunogenetique de la Polyarthrite Rhumatoide
2 LA CONCEPTION - Hôpital de la Conception [CHU - APHM]
3 RIATE - Réseau interdisciplinaire pour l’aménagement et la cohésion des territoires de l’Europe et de ses voisinages

OBJECTIVE: To identify new IgG autoantibodies in sera from patients with rheumatoid arthritis (RA). METHODS: We tested serum samples from 19 patients with RA with given human leukocyte antigen (HLA)-DR genotypes, from 7 patients with spondylarthropathy, 2 patients with lupus, 4 patients with systemic sclerosis and 10 healthy individuals on 8268 human protein arrays. RESULTS: We identified four antigens (peptidyl arginine deiminase 4 (PAD4), protein kinase Cbeta1 (PKCbeta1), phosphatylinositol 4 phosphate 5 kinase type II gamma (PIP4K2C) and v raf murine sarcoma viral oncogene homologue B1 catalytic domain (BRAF)) that were recognised almost uniquely by sera from patients with RA on protein arrays. Using purified proteins, we confirmed that PAD4 and BRAF are recognised almost uniquely by patients with RA. CONCLUSION: We identified PAD4 and BRAF as RA specific autoantigens.

Domaines: Sciences du Vivant [q-bio]; Immunologie

Isabelle Auger, N Balandraud, J Rak, N. Lambert, M. Martin, et al.. New autoantigens in rheumatoid arthritis (RA): screening 8268 protein arrays with sera from patients with RA. Annals of the Rheumatic Diseases, 2009, 68 (4), pp.591-594. ⟨10.1136/ard.2008.096917⟩. ⟨inserm-02440912⟩